Pinocembrin relieves lipopolysaccharide and bleomycin induced lung inflammation via inhibiting TLR4-NF-κB-NLRP3 inflammasome signaling pathway
Wenhua Gan(China Pharmaceutical University), Cheng Yang(Anhui Medical University), Kaiyue Helian(Australian National University), Mengqi Cui(Nara Institute of Science and Technology), Honggang Zhou(Nankai University), Wen Ning(Chinese Academy of Agricultural Sciences), Ming Wang(Wenzhou Medical University), Rui Liu(Beijing University of Agriculture), Ting Xiao(Chinese Academy of Medical Sciences & Peking Union Medical College), Xiaohe Li(Qilu Hospital of Shandong University), Yunyao Cui(Nankai University), Shanfa Ren(Nankai University), Yiying Wei(Nankai University)
Cited by 31
Related Papers
2019 Global NAFLD Prevalence: A Systematic Review and Meta-analysis
|Clinical Gastroenterology and Hepatology|2021|708
Factors Associated With Prolonged Viral RNA Shedding in Patients with Coronavirus Disease 2019 (COVID-19)
|Clinical Infectious Diseases|2020|556
Comprehensive gene expression profiles reveal pathways related to the pathogenesis of chronic obstructive pulmonary disease
|Proceedings of the National Academy of Sciences|2004|327
Carbon Monoxide Induces Cytoprotection in Rat Orthotopic Lung Transplantation via Anti-Inflammatory and Anti-Apoptotic Effects
|American Journal Of Pathology|2003|221
Follistatin-like 1 (Fstl1) is a bone morphogenetic protein (BMP) 4 signaling antagonist in controlling mouse lung development
|Proceedings of the National Academy of Sciences|2011|220